In vitroneurotoxic properties and excitatory aminoacids concentration in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Relationship with the degree of certainty of disease diagnoses-Reference-Cited by-同舟云学术

In vitroneurotoxic properties and excitatory aminoacids concentration in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Relationship with the degree of certainty of disease diagnoses

Published:2010-02 Issue:2 Volume:121 Page:120-126
ISSN:0001-6314
Container-title:Acta Neurologica Scandinavica
language:en
Short-container-title:

Author:

Fiszman M. L.,Ricart K. C.,Latini A.,RodrÃguez G.,Sica R. E. P.

Publisher

Wiley

Subject

Neurology (clinical),Neurology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0404.2009.01200.x/fullpdf

Reference33 articles.

1. Target in ALS: designing multidrug therapies;Carri;Trends Pharmacol Sci,2006

2. Glutamate neurotoxicity and diseases of the nervous system;Choi;Neuron,1988

3. Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists;Choi;J Neurosci,1988

4. Excitatory amino acid neurotoxicity and neurodegenerative disease;Meldrum;Trends Pharmacol Sci,1990

5. Excitatory amino acids as a final common pathway for neurological disorders;Lipton;N Engl J Med,1994

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuronal Circuit Dysfunction in Amyotrophic Lateral Sclerosis;Cells;2024-05-07

2. Enhanced levels of fractalkine and HSP60 in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients;International Journal of Neuroscience;2024-04-29

3. Glutamine metabolism in diseases associated with mitochondrial dysfunction;Molecular and Cellular Neuroscience;2023-09

4. Metabolomics as a Crucial Tool to Develop New Therapeutic Strategies for Neurodegenerative Diseases;Metabolites;2022-09-14

5. TDP-43 Proteinopathy Causes Broad Metabolic Alterations including TCA Cycle Intermediates and Dopamine Levels in Drosophila Models of ALS;Metabolites;2022-01-21